Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2024 Filed Feb 22, 2024 02:28 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Tax withholdingCommon Stock | 196 | $219.08 | $42,939.68 |
DisclosureSEC source: 0001127602-24-006213 · form4.xml · nonDerivative · entry 4 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,417.9895 Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:28 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionCommon Stock | 404 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006213 · form4.xml · nonDerivative · entry 3 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,613.9895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:28 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Tax withholdingCommon Stock | 414 | $219.08 | $90,699.12 |
DisclosureSEC source: 0001127602-24-006213 · form4.xml · nonDerivative · entry 2 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,209.9895 Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:28 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionCommon Stock | 856 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006213 · form4.xml · nonDerivative · entry 1 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,623.9895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
OtherRestricted Stock Unit · Derivative | 485 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · derivative · entry 8 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 485 shares Expires 2024-02-18 F2 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. F1 · derivative.exercise_date: This award was granted to the reporting person on February 18, 2021. The number of Restricted Stock Units ("RSUs") reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 389 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · derivative · entry 7 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 485 Underlying: Common Stock · 389 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award was granted to the reporting person on February 18, 2021. The number of Restricted Stock Units ("RSUs") reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
Exercise / conversionPerformance Stock Unit · Derivative | 819 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · derivative · entry 6 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 819 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
SaleCommon Stock | 108 | $221.49 | $23,920.92 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · nonDerivative · entry 5 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,148.0915 Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
Tax withholdingCommon Stock | 173 | $219.08 | $37,900.84 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · nonDerivative · entry 4 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,256.0915 Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
Exercise / conversionCommon Stock | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · nonDerivative · entry 3 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,429.0915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
Tax withholdingCommon Stock | 295 | $219.08 | $64,628.60 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · nonDerivative · entry 2 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,040.0915 Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 02:27 UTC |
Singhal PriyaHead of Development
|
Exercise / conversionCommon Stock | 819 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006212 · form4.xml · nonDerivative · entry 1 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,335.0915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 02:13 UTC |
Rowinsky Eric KDirector
|
PurchaseCommon Stock | 455 | $222.54 | $101,255.70 |
DisclosureSEC source: 0001127602-24-005922 · form4.xml · nonDerivative · entry 1 Rowinsky Eric K · CIK 0001318886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,629 Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 23:06 UTC |
Singhal PriyaHead of Development
|
SaleCommon Stock | 419 | $239.45 | $100,329.55 |
DisclosureSEC source: 0001127602-24-004801 · form4.xml · nonDerivative · entry 3 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,516.0915 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:14 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,158 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004805 · form4.xml · derivative · entry 3 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,158 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:14 UTC |
Gregory GingerEVP, Human Resources
|
Tax withholdingCommon Stock | 634 | $240.98 | $152,781.32 |
DisclosureSEC source: 0001127602-24-004805 · form4.xml · nonDerivative · entry 2 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,143.716 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:14 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionCommon Stock | 2,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004805 · form4.xml · nonDerivative · entry 1 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,777.716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:06 UTC |
Singhal PriyaHead of Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,212 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004801 · form4.xml · derivative · entry 4 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,212 Underlying: Common Stock · 1,212 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award was granted to the reporting person on February 10, 2022 and will vest in three equal installments on each anniversary of the grant date. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:06 UTC |
Singhal PriyaHead of Development
|
Tax withholdingCommon Stock | 374 | $240.98 | $90,126.52 |
DisclosureSEC source: 0001127602-24-004801 · form4.xml · nonDerivative · entry 2 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,935.0915 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:06 UTC |
Singhal PriyaHead of Development
|
Exercise / conversionCommon Stock | 1,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004801 · form4.xml · nonDerivative · entry 1 Singhal Priya · CIK 0001769608 · Head of Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,309.0915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:04 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,272 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004800 · form4.xml · derivative · entry 3 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,272 Underlying: Common Stock · 2,272 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:04 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Tax withholdingCommon Stock | 761 | $240.98 | $183,385.78 |
DisclosureSEC source: 0001127602-24-004800 · form4.xml · nonDerivative · entry 2 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,767.9895 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:04 UTC |
Murphy NicoleHead of Pharm Ops and Tech
|
Exercise / conversionCommon Stock | 2,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004800 · form4.xml · nonDerivative · entry 1 Murphy Nicole · CIK 0001910644 · Head of Pharm Ops and Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,528.9895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:03 UTC |
McDonnell Michael R.EVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,257 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004799 · form4.xml · derivative · entry 3 MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:03 UTC |
McDonnell Michael R.EVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 1,431 | $240.98 | $344,842.38 |
DisclosureSEC source: 0001127602-24-004799 · form4.xml · nonDerivative · entry 2 MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,124 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:03 UTC |
McDonnell Michael R.EVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 3,257 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004799 · form4.xml · nonDerivative · entry 1 MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:01 UTC |
Kramer RobinChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004797 · form4.xml · derivative · entry 3 Kramer Robin · CIK 0001609222 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834 Underlying: Common Stock · 833 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:01 UTC |
Kramer RobinChief Accounting Officer
|
Tax withholdingCommon Stock | 245 | $240.98 | $59,040.10 |
DisclosureSEC source: 0001127602-24-004797 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,277.7483 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:01 UTC |
Kramer RobinChief Accounting Officer
|
Exercise / conversionCommon Stock | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004797 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,522.7483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,515 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004794 · form4.xml · derivative · entry 3 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,515 Underlying: Common Stock · 1,515 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Tax withholdingCommon Stock | 445 | $240.98 | $107,236.10 |
DisclosureSEC source: 0001127602-24-004794 · form4.xml · nonDerivative · entry 2 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,636 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 23:00 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionCommon Stock | 1,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004794 · form4.xml · nonDerivative · entry 1 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:56 UTC |
ALEXANDER SUSAN HEVP Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,575 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004786 · form4.xml · derivative · entry 3 ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,575 Underlying: Common Stock · 2,575 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:56 UTC |
ALEXANDER SUSAN HEVP Chief Legal Officer
|
Tax withholdingCommon Stock | 938 | $240.98 | $226,039.24 |
DisclosureSEC source: 0001127602-24-004786 · form4.xml · nonDerivative · entry 2 ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,083 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:56 UTC |
ALEXANDER SUSAN HEVP Chief Legal Officer
|
Exercise / conversionCommon Stock | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004786 · form4.xml · nonDerivative · entry 1 ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:16 UTC |
ALEXANDER SUSAN HEVP Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004311 · form4.xml · derivative · entry 4 ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,380 Underlying: Common Stock · 2,190 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 2/8/2023. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:16 UTC |
ALEXANDER SUSAN HEVP Chief Legal Officer
|
Tax withholdingCommon Stock | 655 | $240.30 | $157,396.50 |
DisclosureSEC source: 0001127602-24-004311 · form4.xml · nonDerivative · entry 2 ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,446 Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:16 UTC |
ALEXANDER SUSAN HEVP Chief Legal Officer
|
Exercise / conversionCommon Stock | 2,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004311 · form4.xml · nonDerivative · entry 1 ALEXANDER SUSAN H · CIK 0001263839 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:14 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,635 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004310 · form4.xml · derivative · entry 4 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,270 Underlying: Common Stock · 1,635 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:14 UTC |
Gregory GingerEVP, Human Resources
|
Tax withholdingCommon Stock | 498 | $240.30 | $119,669.40 |
DisclosureSEC source: 0001127602-24-004310 · form4.xml · nonDerivative · entry 2 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,619.716 Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:14 UTC |
Gregory GingerEVP, Human Resources
|
Exercise / conversionCommon Stock | 1,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004310 · form4.xml · nonDerivative · entry 1 Gregory Ginger · CIK 0001545716 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,117.716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:11 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,043 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004308 · form4.xml · derivative · entry 4 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,087 Underlying: Common Stock · 2,043 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:11 UTC |
Izzar RachidHead of Global Product Strat.
|
Tax withholdingCommon Stock | 621 | $240.30 | $149,226.30 |
DisclosureSEC source: 0001127602-24-004308 · form4.xml · nonDerivative · entry 2 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,566 Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:11 UTC |
Izzar RachidHead of Global Product Strat.
|
Exercise / conversionCommon Stock | 2,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004308 · form4.xml · nonDerivative · entry 1 Izzar Rachid · CIK 0001875506 · Head of Global Product Strat. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:06 UTC |
Kramer RobinChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 788 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004306 · form4.xml · derivative · entry 4 Kramer Robin · CIK 0001609222 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,577 Underlying: Common Stock · 788 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:06 UTC |
Kramer RobinChief Accounting Officer
|
Tax withholdingCommon Stock | 253 | $240.30 | $60,795.90 |
DisclosureSEC source: 0001127602-24-004306 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,689.7483 Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:06 UTC |
Kramer RobinChief Accounting Officer
|
Exercise / conversionCommon Stock | 788 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004306 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,942.7483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:03 UTC |
McDonnell Michael R.EVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004305 · form4.xml · derivative · entry 4 MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,670 Underlying: Common Stock · 2,335 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:03 UTC |
McDonnell Michael R.EVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 765 | $240.30 | $183,829.50 |
DisclosureSEC source: 0001127602-24-004305 · form4.xml · nonDerivative · entry 2 MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,298 Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:03 UTC |
McDonnell Michael R.EVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004305 · form4.xml · nonDerivative · entry 1 MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.